
Recent Decision in FCA Case Has Key Implications for Labs
A January summary judgment has added to the split among courts when it comes to determining labs’ liability under the False Claims Act
A January summary judgment has added to the split among courts when it comes to determining labs’ liability under the False Claims Act
Cases filed or resolved by the U.S. Department of Justice in the fourth quarter reveal the same compliance issues from early in 2024
Recent False Claims Act settlements underscore the government’s emphasis on individual accountability in healthcare fraud matters
Recent enforcement actions involved usual targets such as COVID-19, genetic, and urine drug testing, but EKRA also made an appearance
Recent DOJ settlements continue to focus on issues involving medical necessity and marketer compensation